Exploring Dopamine. To explore a different substance…

Names:
Dopamine · 3,4-Dihydroxyphenethylamine
IUPAC name:
4-(2-Aminoethyl)benzene-1,2-diol
ID: 2012 · Formula: C8H11NO2 · Molecular weight: 153.178
Tags: Peyote alkaloid
InChI: InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2

Lieberman, JA; Mailman, RB; Duncan, G; Sikich, L; Chakos, M; Nichols, DE; Kraus, JE. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol. Psychiat., 1 Dec 1998, 44 (11), 1099–1117. 154 kB. http://dx.doi.org/10.1016/S0006-3223(98)00187-5

Reviriego, F; Navarro, P; Domènech, A; García-España, E. Effective complexation of psychotropic phenethylammonium salts from a disodium dipyrazolate salt of macrocyclic structure. J. Chem. Soc. Perkin Trans. 2, 2002, 1634–1638. 115 kB. http://dx.doi.org/10.1039/b200607c

Partilla, JS; Dempsey, AG; Nagpal, AS; Blough, BE; Baumann, MH; Rothman, RB. Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J. Pharmacol. Exp. Ther., 1 Oct 2006, 319 (1), 237–246. 367 kB. http://dx.doi.org/10.1124/jpet.106.103622

Nichols, DE. Potential psychotomimetics: Bromomethoxyamphetamines and structural congeners of lysergic acid. Ph. D. Thesis, University of Iowa, Iowa City, IA, 1 May 1973. 13.0 MB.

Chemel, BR; Bonner, LA; Watts, VJ; Nichols, DE. Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D1 receptor catechol agonists. Mol. Pharmacol., 1 May 2012, 81 (5), 729–738. 1.2 MB. http://dx.doi.org/10.1124/mol.111.077339

Short, JH; Dunnigan, DA; Ours, CW. Synthesis of phenethylamines from phenylacetonitriles obtained by alkylation of cyanide ion with Mannich bases from phenols and other benzylamines. Tetrahedron, 1973, 29 (14), 1931–1939. 791 kB. http://dx.doi.org/10.1016/0040-4020(73)80127-9

Horn, AS. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates. Br. J. Pharmacol., 1 Feb 1973, 47 (2), 332–338. 903 kB. http://dx.doi.org/10.1111/j.1476-5381.1973.tb08331.x

N-Me-DHPEA · Epinine
N-Me,N-iPr-DHPEA
N,N-Me-DHPEA
N-Et-DHPEA
N-Bu-DHPEA
N-iBu-DHPEA
α-Me-DA
DH-α-Et-PEA
α-Carboxy-DHA
Norepinephrine
β-Me-DHPEA
Tyramine
3-MT
3-Cl-4-HPEA
3-NO2-HPEA
3-HPEA
HMPEA
3,4-DESMETHYL
3,4,5-DESMETHYL
MDPEA
F2-MDPEA
EDPEA
DHBA
homo-Dopamine
DHPEA-βk
3,4-DHO-CPA
ADTN
β-HO-HPEA · Octopamine
β-HO-2-HPEA
β-HO-3-HPEA
2,3-DHPEA
2,4-DHPEA
3,5-HPEA
2,6-HPEA
2,5-HO-PEA
N-Me-DHPEA · Epinine
N-Me,N-iPr-DHPEA
N,N-Me-DHPEA
N-Et-DHPEA
N-Bu-DHPEA
N-iBu-DHPEA
α-Me-DA
DH-α-Et-PEA
α-Carboxy-DHA
Norepinephrine
β-Me-DHPEA
Tyramine
3-MT
3-Cl-4-HPEA
3-NO2-HPEA
3-HPEA
HMPEA
3,4-DESMETHYL
3,4,5-DESMETHYL
MDPEA
F2-MDPEA
EDPEA
DHBA
homo-Dopamine
DHPEA-βk
3,4-DHO-CPA
ADTN
β-HO-HPEA · Octopamine
β-HO-2-HPEA
β-HO-3-HPEA
2,3-DHPEA
2,4-DHPEA
3,5-HPEA
2,6-HPEA
2,5-HO-PEA
11 December 2017 · Creative Commons BY-NC-SA ·